Cargando…
Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots
Intermittent androgen deprivation therapy (IADT) is now being increasingly opted by the treating physicians and patients with prostate cancer. The most common reason driving this is the availability of an off-treatment period to the patients that provides some relief from treatment-related side-effe...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Second Military Medical University
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772839/ https://www.ncbi.nlm.nih.gov/pubmed/29387553 http://dx.doi.org/10.1016/j.ajur.2017.04.001 |